Simplify Logo

Full-Time

Scientist I

Protein Analytical Development

Posted on 3/22/2024

Vaxcyte

Vaxcyte

201-500 employees

Develops broad-spectrum bacterial infection vaccines

Hardware
Biotechnology

Senior, Expert

San Carlos, CA, USA

Category
Lab & Research
Life Sciences
Required Skills
Data Analysis
Requirements
  • B.S in Chemistry, Analytical Chemistry, Biochemistry, or related field with 10+ years relative experience; MS with 7 years + industry experience and PhD with 1-4 years experience.
  • Strong technical background in analytical chemistry.
  • Hands on proficiency with HPLC, CE-SDS, Spectroscopy, etc.
  • Perform accurate and reliable data analysis and interpretation of experimental results related to process characterization.
  • Ability to think critically and demonstrate troubleshooting and problem-solving skills.
  • Maintain accurate records of experimental procedures, results and conclusion in compliance with regulatory guidelines.
  • Team player, proactive and willing to work in a collaborative team environment.
  • Scientific creativity and curiosity for applying new technologies to complex analytical challenges.
Responsibilities
  • Set up instrument capabilities for analytical methods development and qualification.
  • Develop/optimize analytical methods for biologic products using various techniques.
  • Acquire and interpret data for protein titer, molecule characterization, and process development studies.
  • Maintain good documentation practices for recording experimental plans and results.
  • Assist in troubleshooting of instrumentation and test methods.
  • Work independently and in a team setting on assigned tasks.
  • Participate in group meetings, present results of work, interpret data, and report results accurately.
  • Work with lab automation to create high throughput methods leveraging liquid handling and robotic technologies.
  • Work in collaboration with other scientists/SME to design experiments and advance more powerful analytical techniques.

Vaxcyte is centered on creating advanced vaccines such as VAX-24, a sophisticated 24-valent pneumococcal conjugate vaccine, by utilizing cutting-edge chemistry and the XpressCF™ cell-free protein synthesis platform. The company prioritizes developing high-fidelity, broad-spectrum vaccines to combat bacterial infections, continuously expanding its product pipeline with innovations like VAX-31 for various bacterial threats.

Company Stage

IPO

Total Funding

$2.3B

Headquarters

Foster City, California

Founded

2013

Growth & Insights
Headcount

6 month growth

25%

1 year growth

50%

2 year growth

120%
INACTIVE